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Abstract
When cells swell in hypo-osmotic solutions, chloride-selective ion channels (Clswell) activate to reduce intracellular osmolality
and prevent catastrophic cell rupture. Despite intensive efforts to assign a molecular identity to the mammalian Clswell
channel, it remains unknown. In an unbiased genome-wide RNA interference (RNAi) screen of Drosophila cells stably
expressing an anion-sensitive fluorescent indicator, we identify Bestrophin 1 (dBest1) as the Drosophila Clswell channel. Of
the 23 screen hits with mammalian homologs and predicted transmembrane domains, only RNAi specifically targeting
dBest1 eliminated the Clswell current (IClswell). We further demonstrate the essential contribution of dBest1 to Drosophila
IClswell with the introduction of a human Bestrophin disease-associated mutation (W94C). Overexpression of the W94C
construct in Drosophila cells significantly reduced the endogenous IClswell. We confirm that exogenous expression of dBest1
alone in human embryonic kidney (HEK293) cells creates a clearly identifiable Drosophila–like IClswell. In contrast, activation
of mouse Bestrophin 2 (mBest2), the closest mammalian ortholog of dBest1, is swell-insensitive. The first 64 residues of
dBest1 conferred swell activation to mBest2. The chimera, however, maintains mBest2-like pore properties, strongly
indicating that the Bestrophin protein forms the Clswell channel itself rather than functioning as an essential auxiliary
subunit. dBest1 is an anion channel clearly responsive to swell; this activation depends upon its N-terminus.
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Introduction
All mammalian cells express chloride channels activated by
decreases in extracellular osmolality, albeit with different biophys-
ical properties [1]. The ubiquitous expression of Clswell suggests its
essential cellular function. Tightly regulated Clswell channels
participate in volume regulation, motility, cell survival, and cell
division [1]. In contrast, de-regulated constitutively active Clswell
channels exacerbate several cardiac diseases, including myocardial
hypertrophy and heart failure [2]. The mammalian Clswell
channel- encoding gene has yet to be identified despite the wealth
of proteins nominated by candidate approaches [3]. These
proteins include ClC-2 [4], ClC-3 [5], P-glycoprotein [6,7], pICln
[8,9], p64 [10], phospholemman [11], Best1 and 2 [12],
TMEM16A [13], and TMEM16F [14]. The research community
has yet to agree on any of these candidates as a bona fide Clswell
channel.
In Drosophila, however, accumulating evidence indicates that
dBest1 encodes for a Clswell channel. RNAi targeting dBest1
eliminates Drosophila Schneider (S2) cell IClswell, an effect rescued
by re-introduction of dBest1 [15]. Further, swell activated dBest1
mutants have altered biophysical properties and reactivity to
sulfhydryl reagents [16]. dBest1 likely forms the chloride
conducting pore, but it may be an obligate auxillary subunit of
Drosophila IClswell that modifies channel properties akin to CaV b
subunits [17].
Assigning chloride channel function to any protein is difficult.
The known chloride channel families (e.g., ClC, Anoctamin/
TMEM16, CFTR, and ionotropic GABAA and GlyR) lack
structural pore or gating motifs that might form the basis for in
silico identification. Expression cloning approaches have also failed
due to widespread Clswell channel expression that precludes the
separation of endogenous and over-expressed protein activities.
Moreover, known chloride channels blockers are non-specific and
their affinities are far too low to encourage affinity purification.
Finally, previous chloride indicators are poor tools for screening
due to loading and retention issues, inconsistent results, and poor
reproducibility [18].
Here we present an unbiased genome-wide, high-throughput
RNAi screen designed to identify the Drosophila Clswell channel and
its regulators. Our screen employed H148Q-YFP, a genetically
encoded anion-sensitive yellow fluorescent protein [19], to report
Clswell activity in Drosophila S2R+ cells. Of our 595 initial hits that
altered chloride handling, we concentrated on characterizing
proteins with mammalian homology and at least one transmem-
brane domain as potential Clswell channels. dBest1 emerged from
our screen as the lead candidate for Drosophila Clswell. Both RNAi
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dBest1 eliminated the Clswell current in Drosophila S2R+ cells.
Conversely, dBest1 overexpression in a mammalian system (HEK
cells) produced a Drosophila–like IClswell. To identify domains
necessary for swell activation we characterized chimeras between
the swell-sensitive dBest1 and the swell-insensitive mBest2. Swell
sensitivity is only apparent in mBest2, the closest mammalian
homolog of dBest1, when the protein contains the dBest1 amino
(N)-terminus. This chimera maintains the pore properties of
mBest2, providing additional evidence that the protein itself forms
a channel rather than functioning as a necessary auxiliary subunit.
We conclude that dBest1 is the channel underlying the Drosophila
IClswell.
Results
Drosophila S2R+ Cells have Robust IClswell
Drosophila S2 cells are used extensively in genome-wide RNAi
screens to dissect signaling pathways, determine protein functions,
and assign protein molecular identity [20]. These macrophage-like
cells, derived from primary culture of late stage Drosophila
melanogaster embryos [21] readily take up RNAi from serum-free
media. The subsequent process of targeted mRNA ablation is
efficient and highly reproducible [22,23]. For our screen we used
S2R+ cells [24], an adherent S2 variant well suited for assays that
require multiple solution changes. Importantly, S2R+ cells have a
consistent, large IClswell that activates slowly upon a drop in
extracellular osmolality (Figure 1A). IClswell starts to activate within
2 min exposure to hypo-osmotic media, reaching steady state
activation by 5 min. The fully activated Clswell conductance is
anion selective (Figure 1B). The relative permeability sequence of
S2R+ Clswell is I=SCN.Cl.MES.aspartate (ASP) while the
slope conductance sequence is I=SCN=Cl.MES.ASP (Table 1
& 2). The Clswell I–V relationship has a slight ‘‘S’’ shape, revealing
rectification. An extended step protocol further illustrates features
of S2R+ Clswell (Figure 1C). IClswell exhibits an initial instantaneous
activation followed by a second slow activation phase, suggesting
that more than one type of Cl
2 conductance is turned on in S2R+
cells with cell swelling. In contrast, Chien & Hartzell [15] reported
a single phase, time-independent IClswell activation in their S2 cells,
perhaps indicating Cl
2 channel expression differences in the two
cell lines. Tail currents, normally indicating time dependence of
deactivation of the channel, are evident in our recordings.
However, since tail currents were not observed under symmetrical
recording conditions [15], we attribute these currents to the exit of
intracellular Cl
2 accumulated during the prolonged steps. S2R+
IClswell has an interesting pharmacological profile (Figure 2A).
Even at a high concentration (100 mM), the non-specific chloride
channel blocker 4,49-diisothiocyano-2,29-stilbenedisulfonic acid
(DIDS) [25] blocks less than 25% of the S2R+ IClswell
(Figure 2A). 4-2(2-butyl-6,7-dichloro-2-cyclopentyl-indan-1-on-5-
yl (DCPIB), a mammalian selective IClswell blocker [26], fails to
completely block S2R+ IClswell at 30 mM (Figure 2A & E). DCPIB
blocks in a voltage-dependent manner (Figure 2E); at 0 mV 52%
of S2R+ IClswell is blocked, while 90% is blocked at 80 mV.
Surprisingly, furosemide, a Na-K-2Cl cotransporter (NKCC;
SLC12A2) blocker, almost completely inhibits S2R+ IClswell at
1 mM (Figure 2A & 3C).
H148Q-YFP Reliably Reports the Activity of S2R+ Cell
Clswell Channels
Clswell conducts iodide better than chloride, favoring the use of
the H148Q-YFP indicator as a reporter of its activity (I
2
KD=20 mM and Cl
2 KD=100 mM [19,27,28]). Several anion-
sensitive YFP variants accurately quantify intracellular Cl
2
concentration or changes [27,29–31]; anion binding near the
YFP chromophore suppresses fluorescence emission by altering
chromophore resonance [19]. H148Q-YFP was chosen for Clswell
detection because it is bright and potently suppressed by I
2; these
properties are critical for good signal-to-noise ratios during
screening. H148Q-YFP (pKa=6.7) is also sensitive to intracellular
pH changes [19,28]. S2R+ cells stably expressing H148Q-YFP
maintain their fluorescence in 240 mOSM NaCl however
(Figure 3A), indicating that cell swelling does not appreciably
alter intracellular pH. Subsequent replacement of bath Cl
2 with
I
2 rapidly suppresses indicator fluorescence by 50% as I
2 enters
the cells through open channels and interacts with the probe. The
large fluorescence change and low intrinsic assay variability favor
clear separation of potential hits. In the absence of hypo-osmotic
solution, I
2 is unable to enter the S2R+ cells and fluorescence is
maintained (Figure 3B), indicating that S2R+ cells lack alternative
constitutively active I
2 entry pathways that could confound our
ability to identify the Clswell channel. Further, furosemide block of
open Clswell channels prevents appreciable fluorescence suppres-
sion (Figure 3C & D), suggesting that RNAi effectively targeting
the Clswell channel will be readily identifiable as hits.
Genome-wide RNAi Screening of H148Q-YFP S2R+ Cells
Identifies dBest1 as the Clswell Channel
The primary screen was conducted at the Harvard/HHMI
Drosophila RNAi Screening Center using our stable H148Q-YFP-
expressing S2R+ cell line. Each well of sixty-six 384-well assay
plates contained a dsRNA targeting 1 of 13,900 genes encoding
proteins or non-coding RNAs (DRSC 2.0; Figure 4A). Five days
after S2R+ cells were treated with RNAi, we assessed cellular
fluorescence under swell conditions in the presence of Cl
2 and I
2.
Wells with fluorescence or ratio (I
2 fluorescence/Cl
2 fluorescence)
changes greater than 1.5 times the standard deviation of the plate
mean were initially considered as hits (Clswell channel candidates
or regulators of its activation pathway). We pared the list of 595
hits to genes with mammalian homologs and those with predicted
transmembrane domains (Figure 4B, Table S1). In a secondary
screen, we confirmed that each RNAi significantly reduced
swelling-induced fluorescence and targeted only the mRNA from
the identified gene (qPCR). We then directly measured IClswell via
whole-cell voltage clamp. Candidates genes, whose RNAi signif-
icantly reduced the S2R+ cell IClswell, were cloned and expressed in
HEK293 or CHO-K1 cells. IClswell was then measured via whole-
cell recording and compared with currents from untransfected
cells. The only candidate of our screen to satisfy all the criteria for
aC l swell channel was dBest1 (Table S1).
DRSC26457 RNAi Targeting dBest1 Eliminates IClswell
dBest1 is a protein of 769 amino acids containing 4
transmembrane domains [32,33] (Figure 4C). It is one of four
Bestrophin family members in Drosophila, with highest homology to
mBest2/hBest2 (51% identity and 67% similarity; BLAST).
Hartzell and colleagues first proposed that dBest1 was a chloride
channel activated by high intracellular Ca
2+ and cell swelling
[15,16]. In our H148Q-YFP fluorescence assay dBest1 RNAi
DRSC26457 abrogated the fluorescence change normally ob-
served when I
2 enters the S2R+ cells through activated Clswell
conductances (Figure 5A, B). Interestingly, DRSC26457 also
decreased the baseline fluorescence variability of S2R+ cells
(Figure 5B), suggesting that IdBest1 contributes to resting intracel-
lular Cl
2 concentrations. S2R+ IClswell was essentially eliminated
by dBest1 RNAi DRSC26457 treatment (Figure 5C). This RNAi
specifically and effectively reduced dBest1 mRNA by 91.5% 60.5
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members and other Clswell candidates were unaffected. A second
RNAi targeting dBest1 (DRSC16909; corresponds with dB1S
[15]) was part of our initial screen. It was less effective at knocking
down dBest1 mRNA (85% reduction, n=3; significantly less than
DRSC26457; p,0.001, Student’s t-test) and had two predicted
off-target hits: CG4623 (20/20) and CG16711 (18/18).
DRSC16909 did not significantly alter H148Q-YFP I
–induced
Figure 1. Characterization of the S2R+ cell IClswell. (A) Hypo-osmotic solutions slowly activate IClswell.I Clswell begins to activate 1.760.3 min after
exposure to 200 mOSM solution and reaches steady state activation within 560.3 min (n=13). IClswell was assessed in ramp protocols and reported at
+84.5 mV (upper trace) and -115.5 mV (lower trace). 240 mOSM stimulates IClswell activation slightly more slowly (1.860.3 min to initiation and
5.260.6 min to steady state, n=12; data not shown). (B) The S2R+ cell IClswell is anion-selective. IClswell was activated by 200 mOSM solution; relative
permeability and slope conductance sequences were determined for the steady state IClswell by replacing Cl
2 with equimolar anion concentrations.
(C) An extended step protocol (red inset) reveals more than one set of activation kinetics with offset activation initiation times.
doi:10.1371/journal.pone.0046865.g001
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PLOS ONE | www.plosone.org 3 October 2012 | Volume 7 | Issue 10 | e46865Figure 2. Pharmacological profiles of S2R+ IClswell and IdBest1 match and differ from those of HEK IClswell and Id64m. (A–D) % Block of
S2R+ IClswell,I dBest1, HEK IClswell and Id64m by 1 mM furosemide, 100 mM DIDS, and 30 mM DCPIB. Block at 0 mV is presented to emphasize the
incomplete voltage-dependent DCPIB block of S2R+ IClswell and IdBest1. (A) Steady state S2R+ IClswell activated by 200 mOSM stimulation was blocked
96% 61.6 by furosemide, 19% 64 by DIDS, and 52% 610.6 by DCPIB. * no difference compared to IdBest1 block and significantly different compared
to HEK IClswell and Id64m (ANOVA, p,0.05). (B) IdBest1, stimulated for 2 min by 200 mOSM, was blocked 96% 61.7 by furosemide, 44% 610 by DIDS,
and 47% 610.9 by DCPIB. * no difference compared to S2R+ IClswell block and significantly different compared to HEK IClswell and Id64m (ANOVA,
p,0.05). (C) Steady-state HEK IClswell activated by 200 mOSM stimulation was blocked 7% 63.5 by furosemide, 77% 63 by DIDS, and 99% 60.7 by
DCPIB. (D) Constitutive Id64m (320 mOSM) was blocked 77% 63 by furosemide, 98% 61.5 by DIDS, and 98% 61.2 by DCPIB.  significantly different
compared to S2R+ IClswell, HEK IClswell and Id64m (ANOVA, p,0.05). (E–F) I–V relations for S2R+ IClswell and IdBest1 demonstrate DCPIB voltage-dependent
block. At 80 mV, DCPIB block of S2R+ IClswell is 90% 63.6 (n=6), and 82% 66.5 for IdBest1 (n=7).
doi:10.1371/journal.pone.0046865.g002
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initial screen. It is possible that the 15% remaining mRNA
translated sufficient amounts of functional dBest1/Clswell channels
to exclude it as a hit in our screen. This prospect emphasizes the
importance of validated, effective RNAi for accurate screening.
Mutant dBest1 W94C Significantly Reduces S2R+ IClswell
To substantiate the conclusion that dBest1 is an essential
component of the Clswell channel, we tested whether a mutant
dBest1 would act as a dominant negative regulator of IClswell.I n
humans, Bestrophin 1 is mutant in vitelliform macular dystrophy
Figure 3. H148Q-YFP stably expressed in S2R+ cells reports the entry of I
2 through activated Clswell channels. (A) Cellular swelling in
240 mOSM Cl
2 did not alter fluorescence intensity as Clswell channels activate (Student’s t-test, p=0.65; n=76). Replacement of Cl
2 with I
2 evoked a
51% 61.3 decrease in fluorescence (Student’s t-test, p,0.001; n=76). Imaging assay; fluorescence is in arbitrary units (a.u.). (B)C l swell channels must
be open for I
–induced fluorescence suppression to occur. 320 mOSM NaI suppresses fluorescence by 16% 60.7 (Student’s t-test, p=0.1; n=54). (C)
Furosemide, an NKCC2 blocker, completely inhibits the S2R+ cell Clswell channels at 1 mM (n=3). (D) 1 mM Furosemide block of Clswell prevents
significant I
–induced suppression of H148Q-YFP fluorescence (Student’s t-test, p=0.54; n=16).
doi:10.1371/journal.pone.0046865.g003
Table 1. Relative Permeabilities.
PX/PCl n
I SCN Cl MES ASP
S2R+ 1.560.12 1.660.15 1 0.7460.15 0.0760.015 3
dBest1 1.860.05 260.04 1 0.6360.04 0.0960.0017 5
mBest2 1.760.15 2.960.68 1 0.4560.14 0.0560.006 6
d64m 2.260.34 2.660.11 1 0.4360.14 0.0760.011 4
HEK 1.560.06 1.860.2 1 0.6260.0050.1160.003 6
doi:10.1371/journal.pone.0046865.t001
Table 2. Slope Conductance.
Slope Conductance (G; I/V) n
I SCN Cl MES ASP
S2R+ 29.666.8 26.965.9 2867.5 16.463.5 7.661.5 3
dBest1 8.261.5 6.661.1 5.260.7 3.360.4 1.960.3 5
mBest2 1064.9 2.460.95 6.663.4 261.3 1.761.1 6
d64m 1063.5 2.560.36 4.460.3 1.960.5 1.760.3 3
HEK 26.268.2 24.967.1 26.967.9 9.565.4 5.462.7 6
doi:10.1371/journal.pone.0046865.t002
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PLOS ONE | www.plosone.org 6 October 2012 | Volume 7 | Issue 10 | e46865Figure 4. Genome-wide RNAi screening of H148Q-YFP S2R+ cells identifies Clswell channel candidates and regulators. (A) RNAi
treatment alters S2R+ cell H148Q-YFP fluorescence levels. Heat map plate reader data following 5d RNAi treatment (240 mOSM Cl
2). Fluorescence
was subsequently measured in 240 I
2. Wells where the I
2 to Cl
2fluorescence ratio was high are hits. Control RNAis are found in columns 13 and 14.
Thread RNAi is in 13B, 13G, 14K, and 14N. Rho RNAi is in 13D, 13E, 14J, and 14O. GFP RNAi is in 13C, 13F, 14L, and 14M. Wells with elevated
fluorescence in 240 mOSM Cl
2 are shown in red and orange. (B) Functional classification of the 595 hits identified in our screen. 21 hits were
transmembrane proteins of unknown function, putative ion channels, or transporters. 9 candidates with human homology were further evaluated
(Table S1). (C) Protein sequence alignment of dBest1 and mBest2 (Multalign; multalin.toulouse.inra.fr/multalin/). Green bars indicate transmembrane
domains. Yellow bars indicate other putative a-helices (SOSUI; bp.nuap.nagoya-u.ac.jp/sosui/). A red star indicates the W94C mutation. A blue star
indicates the Ca
2+-binding bowl. A pink arrow indicates Stop 383. A pink box outlines the region switched in the d64m chimera.
doi:10.1371/journal.pone.0046865.g004
Figure 5. DRSC26457 identifies dBest1 as Clswell. (A&B ) RNAi efficiently targeting dBest1 prevents significant I
–induced H148Q-YFP
suppression following hypo-osmotic stimulation. Fluorescence is in arbitrary units (a.u.). (A) Plate reader assay. DRSC26457 RNAi treatment resulted in
a fluorescence decrease of 6.4% 619. Control and DRSC16909 RNAi treatment resulted in fluorescence decreases of 40.5% 69.1 and 43.7% 66.2
respectively. * 240 mOSM NaCl and NaI fluorescence levels are significantly different (Student’s t-test, p,0.05). (B) Imaging assay. The fluorescence
levels of individual S2R+ cells treated with control or dBest1 DRSC26457 RNAi were measured during hypo-osmotic stimulation in the sequential
presence of Cl
2 and I
2. The fluorescence of control cells decreased by 56% (n=44); in contrast, the fluorescence of dBest1 DRSC26457 RNAi treated
cells was suppressed by 15% (n=174). (C) dBest1 DRSC26457 RNAi eliminated IClswell in S2R+ cells. Following dBest1 RNAi treatment I320 is not
significantly different from I240 (Student’s t-test, p=0.1). * control and RNAi treated I240 are significantly different (Student’s t-test, p=0.02). (D) dBest1
W94C-gfp overexpression suppresses S2R+ IClswell. * control and W94C-gfp I200 mOSM are significantly different (Student’s t-test, p=0.02). (E) Confocal
images of dBest1 W94C-gfp overexpression in S2R+ cells. Images were obtained before (320 mOSM) and after swell (200 mOSM). Scale bar indicates
10 mm.
doi:10.1371/journal.pone.0046865.g005
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conserved sequence of the channel’s putative pore [36,37]
(Figure 4C). When we expressed the homolog dBest1 W94C-gfp
in S2R+ cells, IClswell was significantly reduced (Figure 5D).
Interestingly, the late activating component of IClswell remained
clearly evident at depolarized potentials (Figure S1). We could not
study this current in more detail as a loss of cell membrane
integrity rapidly ensued. We conclude that dBest1 is responsible
for the early activating S2R+ cell IClswell. W94C might interact
with WT dBest1 to disrupt the Clswell channel pore or it may
prevent proper protein trafficking [38]. In S2R+ cells, dBest1
W94C-gfp has a distinct intracellular expression pattern unaltered
by osmotic changes (Figure 5E), suggesting the latter explanation
over the former. Regardless, dBest1 W94C has a dominant
negative impact on IClswell, further evidence that dBest1 is integral
to the Clswell channel.
Another disease-associated Bestrophin mutation, D308A, occurs
in a putative Ca
2+ -binding bowl located in the channel’s C-
terminus (Figure 4C; blue star). D308A is proposed to eliminate
Bestrophin activation by disruption of calcium binding [39]. We
introduced this mutation into dBest1 to determine if activation by
calcium and cell swelling could be separated. Unfortunately
dBest1 D308A-gfp was not functional in HEK cells (data not
shown). Three possible explanations may underlie this result: 1)
activation by multi-modal stimuli is simultaneously disrupted by
the mutation; 2) the mutation causes protein misfolding and the
channel function has been eliminated for reasons unrelated to
activation; 3) the mutant channel is mislocalized. Our GFP-tagged
protein was expressed (data not shown), but we cannot exclude the
possibility that it mislocalizes or fails to interact appropriately with
other proteins necessary for IClswell activation or channel function
[34].
Exogenous dBest1 Expression Creates a Drosophila-like
IClswell
Exogenous expression of a candidate protein substantiates
whether the protein is necessary and/or sufficient in a given
process. Our secondary screen assessed whether candidate protein
expression resulted in a novel IClswell or augmented the endoge-
nous HEK IClswell (Table S1). The HEK cell line chosen for
candidate over-expression lacked constitutive ICl and ISCN
(potentially contaminating conductances attributable to SLC1A
family member expression [40]; data not shown). The endogenous
HEK IClswell develops very slowly (Figure 6A & B); a two fold
increase was noted within the first 2 min of swell. Once the HEK
IClswell reaches steady state, however, it has increased more than
forty fold (44.4610.7 fold, n=29; Student’s t-test, p,0.000005).
Tail currents are absent (Figure 6B & C). Characteristic voltage-
dependent inactivation develops during steps to positive potentials
(Figure 6C). HEK IClswell is anion selective; its permeability and
conductance sequences match closely to those of S2R+ IClswell
(Figure 6D; Table 1 & 2). The HEK IClswell pharmacological
profile (Figure 2C) correlates well with the literature. 100 mM
DIDS, slightly above the reported IC50 [41], blocks 78% of the
HEK IClswell at +80 mV (Figure 2C). DCPIB has an IC50 of 4 mM
[26]; at 30 mM 100% of HEK IClswell is blocked (Figure 2C).
1 mM furosemide barely inhibits HEK IClswell (Figure 2C). The
endogenous HEK IClswell recapitulates the key features noted for
the mammalian IClswell [1].
Bestrophin proteins are not universally accepted as bona fide
chloride channels; alternatively they are intracellular ion channel
regulators [33,42,43]. dBest1-gfp is clearly observed on or near the
surface of HEK-293 cells (Figure 7A). Its expression results in a
Drosophila-like IClswell (Figure 7B–E). Constitutively active IdBest1 is
apparent in iso-osmotic 320 mOSM solution and is significantly
increased 1664.5 fold (Student’s t-test, p,0.005) during the first
2 min of hypo-osmotic stimulation (Figure 7B). IdBest1 has the same
‘‘S’’-shaped rectification as Drosophila IClswell during ramps
(Figure 7C); tail currents and time-dependent activation are both
apparent in the step protocol (Figure 7d). IdBest1 is anion selective;
it has the same permeability and conductance sequences as S2R+
IClswell and HEK IClswell (Figure 7E; Table 1 & 2). Strikingly, IdBest1
and the endogenous S2R+ IClswell share a similar pharmacological
profile that differs significantly from HEK IClswell (Figure 2A–C).
100 mM DIDS inhibits 35% of IdBest, while 30 mM DCPIB blocks
45%. 1 mM furosemide blocks nearly 100% of the IdBest1.W e
conclude that dBest1 expression results in a Drosophila-like IClswell;
it cannot be attributed to endogenous HEK IClswell upregulation.
dBest1 Swell Activation can be Conferred on the Swell-
insensitive mBest2
The structural domains necessary for swell-induced channel
activation are unknown. Although dBest1 has a long poorly
conserved C-terminus (Figure 4C), it is not necessary for swell
activation. dBest1 remains swell-sensitive despite the removal of up
to 338 of its C-terminal amino acid residues (Stop 383, Figure 4C;
Figure 8A). Next we examined whether chimeras might reveal the
domains underlying swell activation. dBest1’s closest mammalian
homolog, mBest2, is not activated by hypo-osmotic solutions
(Figure 8B). Chimera d64m (the first 64 residues are dBest1; the
remaining residues are identical to those of mBest2; Figure 4C)
expression resulted in a constitutively active current that more
than doubled with swelling (2.3 fold 60.3 increase; Student’s t-test,
p,0.05; Figure 8B–D). The d64m chimera maintained the
relative permeability and slope conductance of mBest2 (Figure 8E
& F; Table 1 & 2), suggesting that the channel’s pore domain is
downstream of residue 64. Two other groups have assessed
mBest2 selectivity [44,45] and found greater permeability for SCN
than we report here. Both groups used high intracellular calcium
to activate ImBest2; we report constitutive ImBest2 measured with
high internal calcium buffering (i.e. ,10 nM free calcium). Our
HEK cell line was also screened for potentially contaminating ISCN
(data not shown) attributable to SLC1A family member expression
[40]. The pharmacological profile of Id64m noticeably diverged
from both that of HEK IClswell and IdBest1 (Figure 2). Furosemide
blocked 75% of Id64m, while DIDS and DCPIB both blocked Id64m
to near completion (Figure 2D). We conclude that the dBest1 N-
terminal domain is required for swell activation of the mBest2
channel. The reverse chimera (m64d) was nonfunctional; exoge-
nous currents were not observed with swelling or in the presence of
high intracellular Ca
2+ (data not shown). We cannot conclude with
this data however, that the N-terminus is a ‘‘swelling’’ domain as it
lacks any predictive motifs. We hypothesize that it works in
concert with domains present both in dBest1 and mBest2 to
facilitate swell activation. The strong correlation between S2R+
IClswell and IdBest1, combined with the unique selectivity and
pharmacology of the d64m chimera, support the conclusion that
the Bestrophin protein itself forms the Clswell channel rather than
functioning as an auxiliary subunit.
Discussion
Our study validates the H148Q-YFP fluorophore as a reliable
reporter of Clswell channel activity in genome-wide RNAi
screening studies. H148Q-YFP has been employed very effectively
in the identification of novel chloride channel activators,
modulators, and blockers of CFTR and Ca
2+-activated Cl
2
channels [18]. This is the first reported RNAi screen using an
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PLOS ONE | www.plosone.org 8 October 2012 | Volume 7 | Issue 10 | e46865Figure 6. The endogenous HEK cell IClswell has characteristic mammalian IClswell properties. (A) HEK cell IClswell develops slowly, reaching
steady state after 5 min exposure to 200 mOSM solution. X indicate min in 200 mOSM. (B) Ramp protocol (inset) assessment of the HEK IClswell. Little
IClswell has developed after 2 min in 200 mOSM solution. The steady state IClswell is outwardly rectifying and inactivating at positive potentials. No tail
currents are apparent. (C) Step protocol (inset) assessment of the HEK IClswell. Rapid inactivation is observed at positive potentials. No tail currents are
apparent. (D) Relative permeability and slope conductance sequences for the endogenous HEK IClswell are SCN=I.Cl..MES.ASP vs
SCN=I=Cl..MES.ASP.
doi:10.1371/journal.pone.0046865.g006
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chloride channel. Our screen supports the findings of the Hartzell
lab [15]: dBest1 RNAi eliminates Drosophila IClswell.
We found that the RNAi effectiveness was essential for Clswell
candidate identification. Two separate dBest1-targeting RNAi’s
were part of our initial screen: DRSC26457 and DRSC16909
Figure 7. dBest1 overexpression in HEK cells produces a S2R+ cell-like IClswell. (A) dBest1-gfp targets to the membrane of HEK cells.
Confocal images of dBest1-gfp overexpressed in HEK-293 cells. The DIC image is on the left, GFP in the middle, overlapped images on the right. Scale
bar indicates 10 mm. (B)I dBest1 rapidly develops within the first 2 min of hypo-osmotic stimulation. (C) The developing IdBest1 has the same ‘‘S’’ shape
rectification as the endogenous S2R+ cell IClswell.( D) Step protocol shows that IdBest1 shares time-dependent activation and tail current properties
with S2R+ cell IClswell.( E) The constitutively active IdBest1 and S2R+ cell IClswell selectivity sequences are very similar. (F)I dBest1 is clearly separable from
the endogenous HEK cell IClswell.I dBest1 increases 15.8 fold 64.5 (n=18; ** paired Student’s t-test, p,0.005) in the first 2 min of hypo-osmotic
stimulation; the endogenous HEK cell IClswell increases 2.1 fold 60.4 (n=29; * paired Student’s t-test, p,0.05).
doi:10.1371/journal.pone.0046865.g007
Identifying the Swell Activated Chloride Channel
PLOS ONE | www.plosone.org 10 October 2012 | Volume 7 | Issue 10 | e46865(which corresponds to dB1S [15]), but only DRSC26457 was a
hit. qPCR reported a 95% reduction in dBest1 mRNA with
DRSC26457 treatment versus an 85% reduction with
DRSC16909. Hartzell and colleagues found that S2 cell IClswell
was significantly reduced following treatment with 0.4 mgo f
DRSC16909 [15], while in our screen each assay well had a
standardized 0.25 mg of RNAi. Using more RNAi may have
effected greater target knockdown and resulted in the detection
of DRSC16909 as a hit in our screen. This result emphasizes
the importance of RNAi effectiveness in hit identification.
Exogenously expressed IdBest1 and endogenous S2R+ IClswell
share similar characteristics, including time-dependent activation,
tail currents, relative permeability sequences, slope conductance
sequences, and pharmacological profiles. The shared properties of
Drosophila IClswell and IdBest1 suggest that the same protein forms the
channel responsible for both. Bestrophin is a known ion channel
modulator, altering voltage-gated calcium channel activity [46]. If
Figure 8. Chimeras between dBest1 and mBest2 confer swell activation on mBest2. (A) Truncation of dBest1 does not interfere with swell
sensitivity. Constitutive currents are apparent with both dBest1 and Stop 383 overexpression in iso-osmotic solutions (320 mOSM). With swell, current
increased dramatically for both constructs (Student’s t-test, * p,0.05, ** p,0.005). (B) d94m current increases significantly within the first 2 min of
swelling (* Student’s t-test, p,0.05). (C) Time course for d64m swell activation. (D) Current-voltage relations for constitutive d64m, and following
2 min 200 mOSM solution. (E) Selectivity sequence for the constitutively active d64m current. (F) Selectivity sequence for the constitutively active
mBest2 currents.
doi:10.1371/journal.pone.0046865.g008
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nous HEK Clswell channel expression, we would have expected the
resulting IClswell to maintain the properties of HEK IClswell. Instead
we observed that dBest1 introduced an exogenous Drosophila-like
IClswell whose development preceeded that of the endogenous
HEK IClswell.I dBest1 matched the pharmacological profile of the
S2R+ IClswell. Moreover, we found that the exogenous Drosophila-
like IClswell permeability and conductance sequence could be
transformed into that of mBest2 with the d64m chimera. The
pharmacological profile of Id64m was again significantly different
from the endogenous HEK IClswell. We conclude that dBest1 is the
Drosophila Clswell channel.
Several Bestrophin mutations are associated with vitelliform
macular dystrophy [36,37]. How these mutations are causally
linked to the disease is not clear. Here we found that
overexpression of the disease-linked W94C dBest1 mutant in
S2R+ cells significantly suppressed the endogenous Drosophila
IClswell. The W94C mutation occurs in the putative pore of dBest1
and thus may disrupt Clswell conductance. However, the fluores-
cently tagged W94C dBest1 protein appears to localize to
intracellular compartments, consistent with mislocalization. Mile-
nkovic et al, have recently proposed that disease-associated
Bestrophin mutations cause defects in intracellular trafficking
[38]. Both scenarios may explain the dominant negative effect of
dBest1 W94C on Drosophila IClswell: non-functional, pore-disrupt-
ing, mutant Bestrophin proteins complexing with wild-type dBest1
may be largely retained within the endoplasmic reticulum. The
end result would be the elimination of endogenous Drosophila
IClswell. Our experiments support the hypothesis that mutant
Bestrophin W93C expression could significantly disrupt chloride
flux and homeostasis in the human macula, contributing to the
disease state.
The distinction of Bestrophin function in Drosophila versus
mammalian cells is most clearly illustrated by Hartzell and
colleagues [16]. IClswell measured in peritoneal mast cells isolated
from mBest12/2, mBest22/2, and mBest1/2 double knockout mice
was identical to wild-type IClswell. hBest1 and mBest2 are swell
sensitive in that their currents are inhibited by hyperosmotic
solutions. However, their activity does not increase with swell [12].
We confirm here that mBest2 activation does not increase when
cells swell. Our d64m chimera contained only a small portion of
dBest1, yet it responded to cellular swelling. The crucial N-
terminal region contains no distinct association domains or
predictive structures that might explain its coupling to changes
in cell stretch, tension, or osmolality. We speculate that the N-
terminus contributes to a required tertiary structure that enables
swell signaling events to activate the dBest1 channel.
Our genome-wide RNAi screen of S2R+ cells and follow-up
study firmly establishes that the dBest1 protein forms the Drosophila
Clswell channel. It further validates a live cell genetically
engineered fluorescent screening platform to identify other
mammalian chloride channels.
Materials and Methods
Generation of the S2R+ YFP- H148Q Stable Cell Line
The stable S2R+ cell line expressing a halide-sensitive YFP
(H148Q-YFP; kindly provided by Dr. Alan Verkman, UCSF) was
generated with a selection vector (pCoBlast). H148Q-YFP was
subcloned into the pAc5.1/V5-HisA vector (Invitrogen, CA). The
S2R+ cells were transfected by electroporation (Amaxa cell line
nucleofector kit V; Lonza). Cells were placed under selective
pressure with 25 mg/ml blasticidin for 2 weeks. Two rounds of
fluorescence-activated cell sorting (FACS; DFCI Flow Cytometry
Core Facility) normalized YFP fluorescence intensities. These
S2R+ cells exhibited a robust IClswell as described in Figure 1.
S2R+ cells were maintained in Schneider’s Drosophila medium
(Invitrogen), with 10% heat inactivated fetal bovine serum
(Invitrogen), and 1% penicillin/streptomycin (Sigma-Aldrich).
For the primary screen, cells were spun down and resuspended
in serum-free medium at a density of 9610
4 cells/ml. 10 ml of the
cell suspension was added to each of the 384 wells using the Matrix
Wellmate 8-channel microplate dispenser (ThermoScientific;
DRSC). Cells were incubated for 30 min, then 30 ml of serum
containing medium were added to each well. Cells were cultured
for 5 d before the swell assay was performed (5 d RNAi treatment
is necessary to sufficiently knock down proteins with slow turnover
rates). For the secondary screen, cells were plated at a density of
40% in a 6 well dish. Once cells were adherent, the medium was
replaced with 1 ml of serum-free medium containing 0.015 mg/ml
dsRNA. Cells were incubated for 30 min at room temperature
followed by addition of 3 ml of serum-containing medium to each
well. Transfections were performed in duplicate; 1 well was used
for functional studies and the other for qPCR analysis of
knockdown at day 5.
Screening Solutions
Iso-osmotic (320 milliOsm/kg; mOSM) solutions contained in
mM: 105 NaCl or NaI, 2 CaCl2, 1 MgCl2, 5 KCl, 10 HEPES, 10
Glucose, 90 Mannitol (pH 7.4 NaOH). For hypo-osmotic (240
mOSM) solutions, mannitol was omitted. 1 mM furosemide
(Sigma-Aldrich) blocked 100% of the S2R+ IClswell and prevented
significant H148Q-YFP suppression. Furosemide is a specific
blocker of Na-K-2Cl co-transporters (SLC12A2) at concentrations
in the mM range.
The Primary Screen
Our genome-wide screen was conducted at the Harvard/
HHMI Drosophila RNAi Screening Center using the DRSC 2.0
Genomewide RNAi Library. DRSC 2.0 is a collection of dsRNAs
for genome-wide RNAi knockdown covering , 13,900 genes
encoding proteins and non-coding RNAs while minimizing off-
target effects due to sequence similarity to other genes. Each gene
is targeted by 1.3 dsRNA/gene. The screen consisted of 66 384-
well assay plates in duplicate. Each well of the 384-well plate
contained 5 ml of 0.05 mg/ml dsRNA in water (0.25 mg dsRNA/
well). Each plate contained control RNAi specific for Thread
(Drosophila inhibitor of apoptosis protein), Rho (a small GTPase
activator of the EGFR signaling pathway), and GFP. On day 5 of
RNAi treatment, the cellular fluorescence of the H148Q-YFP
probe was measured under several treatment conditions using the
Analyst GT plate reader (Molecular Devices; DRSC). The probe
was excited at 485 nm and emissions collected at 530 nm. Before
fluorescence measurements were taken, the media was aspirated
(384-well aspirator; VP Scientific) and the cells were equilibrated
in 80 ml of 320 mOSM NaCl solution. After 10 min this solution
was removed by aspiration and cells incubated in 240 mOSM
NaCl for 5 min. Fluorescence was then measured, the NaCl
solution removed and cells were incubated in 240 mOSM NaI for
5 min. Fluorescence was again measured; the change in fluores-
cence was determined by dividing the fluorescence in 240 mOSM
NaI by that in 240 mOSM NaCl. Wells with fluorescence or ratio
changes (240 mOSM I
2 fluorescence/240 mOSM Cl
2 fluores-
cence) greater than 1.5 times the standard deviation (1.56S.D.) of
the plate mean were initially considered as hits (candidates of
Clswell channel or regulators of its activation pathway). False
positives could potentially result if the RNAi treatment caused a
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detected in control wells indicating effective RNAi treatment.
Generation of dsRNA
cDNA templates were generated by PCR amplification of
genomic DNA using primers designed by the DRSC (SnapDragon
tool). These primers had the T7 promoter sequence (TAATAC-
GACTCACTATAGGG) added to the 5’ end of both primers.
The templates generally corresponded to exons but occasionally
sequences with two or more exons interrupted by introns were
used. The PCR fragments were ,150–600 base pairs in length,
and any complete 19-mer homology to other genes that could lead
to non-specific dsRNA are reported. Individual RNAi sequences
used here are found in the DRSC website (www.flyrnai.org).
dsRNAs against Drosophila were synthesized with the MEGAscript
in vitro transcription kit (Ambion). RNA was purified with the
RNeasyPlus mini kit (Qiagen) and stored at 280uC.
qPCR Analysis of RNAi Efficiency
After 5 d RNAi treatment, RNA was prepared from the S2R+
cells using the RNeasy Plus mini kit (Qiagen). 2.5 mg RNA was used
for each first-strand cDNA synthesis reaction (SuperScript Vilo
cDNA Synthesis kit, Invitrogen). Primers for qPCR were designed
on the NCBI/PrimerBlast site (http://www.ncbi.nlm. nih.gov/
tools/primer-blast/) with the following restrictions: PCR product
size was between 70 and 300 bp, primer melting temperatures were
between 57 and 63uC, primers spanned an exon-exon junction, and
primers were specific to the intended PCR template as determined
by BLAST analysis of the Drosophila melanogaster Refseq mRNA
database. Primer sets were only used if the melting curve had a
single peak. The RT
2 Real-Time SYBR Green/Rox PCR master
mix (SABiosciences) was used for qPCR. qPCR reactions were set
up in quadruplicate to minimize pipetting errors, and run on the
Mastercycler ep Realplex real-time PCR system (Eppendorf).
Average cycle numbers for each primer set were normalized to
either dTaf8 or dAct79b average cycle numbers.
Secondary Screening of Candidates
Comprehensive bioinformatics analysis of the hit list was
performed to identify potential candidates for Clswell. Hits were
limited to those with human homologs and at least a single
transmembrane domain. Potential regulators of the Clswell
activation pathway were left for future consideration. The effects
of RNAi on fluorescence changes were confirmed by plate reader
or imaging experiments. The specificity and effectiveness of the
RNAi was assessed by qPCR. S2R+ cells treated with RNAi were
patch clamped and IClswell was directly measured. Candidates were
cloned and expressed in HEK293 or CHO-K1 cells. IClswell was
measured by whole-cell patch clamp recording.
Electrophysiology
Whole-cell patch clamp recordings were made at room
temperature. Recordings were obtained using an Axopatch
200B amplifier, Digidata 1322A analog-to-digital converter, and
pClamp 8.01 software (Molecular Devices, Union City, CA).
Data were low-pass filtered at 2 kHz and digitized at 5 kHz.
Fire-polished thin or thick wall borosilicate glass pipettes of 3–4
MV resistances were used for recordings; access resistance was
compensated to .80%. Cells were held at 270 mV to clearly
eliminate cells with leaky seals and voltage ramps (400 ms in
duration) from 2100 to +100 mV were applied every 2–5 s.
Liquid junction potentials were corrected during analysis, and
ramp data were plotted between –100 and +80 mV.
Recording Solutions
Internal pipette solution contained (in mM): 160 CsASP, 10
Cs4BAPTA, 4 MgATP, 2 MgCl2, 8 NaCl, and 10 HEPES (pH 7.4
with CsOH). 10 mM BAPTA was used to prevent activation of
channelsbycalciumandtoreducetheendogenousHEKcellIClswell,
which is optimally activated with 100 nM Cai [47]. 240 mOSM
solutioncompositionisdetailedin‘Screeningsolutions’.200mOSM
solutions contained in mM: 82.5 NaCl, NaI, NaSCN, NaMES, or
NaASP, 2 CaCl2, 1 MgCl2, 5 KCl, 10 HEPES, and 10 Glucose
(pH 7.4 with NaOH). 90 mM mannitol was added to bring
osmolalityto320mOSM.Therelativepermeabilitieswereestimated
fromtheGoldman-Hodgkin-Katzequation.Forourcalculations,the
[Cl]i was set to 0 mM. Cells were held at -70 mV during all
recordings,rapidlydepletingCli.Cationpermeabilitywasessentially
nil, as replacement of 200 mOSM NaCl solution with 200 mOSM
NMDG-Cl solution did not change the reversal potential (Erev; data
not shown). Slope conductances were calculated for each anionic
substitution betweentheErevand+80 mV.FortheS2R+andHEK
cells Erev and I+80 mV were measured in 200 mOSM solutions. For
exogenously expressed dBest1, mBest2, and d64m Erev and I+80 mV
were measured in 320 mOSM solutions to prevent contamination
withtheendogenousHEKcellIClswell.TheHEKcelllinechosenfor
over-expression studies had no constitutive ICl (I320 mOSM did not
changewhenswitchingbetweenClandASP),theendogenousIClswell
developedveryslowly,andthecellsdidnothaveanendogenousISCN
(attributable toSLC1A family member expression [40].
Pharmacology
Stock solutions of DIDS (0.1 M in DMSO; Sigma), DCPIB
(50 mM in EtOH; Tocris), and furosemide (1M in DMSO; Sigma)
were prepared and diluted in 320 mOSM or 200 mOSM NaCl
solution to their final concentrations.
Molecular Biology
dBest1 was a kind gift from Dr. Criss Hartzell (Emory University).
All other constructs were either ordered from Open Biosystems or
cloned from a Drosophila cDNA library or Human Brain (whole
MarathonreadycDNAlibrary;BDBiosciences).CandidatecDNAs
were subcloned into pEGFP-N3 (C-terminal tag; BD Biosciences)
andanengineeredRedpTracervector(untagged).Wefoundthatan
N-terminal EGFP tag rendered dBest1 nonfunctional (data not
shown). Using site-directed mutagenesis we introduced the W94C
mutationintodBest1pEGFP-N3(GeneArtsite-directedmutagenesis,
Invitrogen, CA). dBest1 W94C-gfp was then subcloned into the
pAc5.1V5-HisA vector (Invitrogen, CA).
Supporting Information
Figure S1 The late activating component of S2R+ IClswell
remains despite overexpression of dBest1 W94C-gfp. (A)
The late activating component of S2R+ IClswell is isolated after
dominant negative elimination of IdBest1. Inset: Step protocol. (B)
The late activating component of S2R+ IClswell is sharply rectifying
(ramp protocol; inset). Red trace is 320 mOSM solution, blue trace
is 80 s after the 200 mOSM solution change. The late activating
IClswell develops after 36 s in 200 mOSM solution.
(TIF)
Table S1 Secondary screening identifies Best1 as the
Drosophila Clswell channel. Candidates with transmembrane
domains and human homologs were further studied to determine
if they formed the Clswell channel. 3 indicates a positive secondary
screening result; X indicates a negative result. B indicates that
several qPCR primer sets consistently had more than 1 melting
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ness of RNAi knockdown, therefore, could not be determined by
qPCR. ?? indicates that two cells overexpressing SLC1A2 had
substantial ISCN- currents but small IClswell. Thus, SLC1A2
overexpression may upregulate endogenous HEK cell IClswell in
the majority of the population but does not form the channel itself.
HeLa cells treated with SLC1A3 siRNA (which reduced SLC1A2
and SLC1A3 mRNA by 90% and 92% respectively) had unaltered
IClswell (data not shown).
(TIF)
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